ArticleMedical oncology (Northwood, London, England)2014

Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance.

Ze-Rui Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.